COSCIENS Biopharma Inc. CSCI
2.72 USD 0.00 0.00%
At close · Jul 7
- YTD
- +33.99%
- 1 year
- +33.99%
- Open
- 2.72
- Prev close
- 2.72
- Mkt cap
- 8.79M
- Vol
- 0
- Avg vol
- 5.38K
- EPS
- -4.46
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.72
- High
- 2.72
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.31
- Inst. own
- 6.35%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.25
- 200-d avg
- 5.61
- 1y target
- 0.00
MAX chart
Chart tools
Chart is warming up
The all-time price history for CSCI has not been loaded yet. Try again in a moment.
Altman Z-Score
-1.83 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -0.5×
P/S 0.5×
P/B 0.5×
P/FCF -0.5×
EV/EBITDA 0.5×
EV/Sales -0.5×
FCF Yield -220.0%
Gross Margin 49.3%
Operating Margin -132.6%
Net Margin -111.1%
ROE -116.3%
ROIC -65.0%
ROA -43.7%
Revenue 93.0%
Operating Income -294.9%
EPS (diluted) -213.8%
Free Cash Flow -376.1%
Current Ratio 3.3×
Quick Ratio 2.9×
Debt / Equity 0.2×
Net Debt / EBITDA 1.0×
Interest Coverage -142×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2024-12-31